Alector (ALEC) Retained Earnings (2018 - 2026)
Alector (ALEC) posted quarterly Retained Earnings of -$104000.0 for Q1 2026, up 99.99% year-over-year from -$52003.1 in Q1 2025, and up 99.99% quarter-over-quarter from -$972.1 million in Q4 2025.
Alector (ALEC) Retained Earnings (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Retained Earnings for 9 consecutive years, with -$104000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 99.99% year-over-year to -$104000.0; the TTM figure through Mar 2026 stood at -$104000.0 (up 99.99% YoY), while the FY2025 annual figure was -$972.1 million, down 17.24% from the prior year.
- Retained Earnings climbed to -$104000.0 in Q1 2026 per ALEC's latest filing, from -$972.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $992.3 million in Q3 2025 and bottomed at -$972.1 million in Q4 2025.
- Historically, Retained Earnings has averaged -$129.0 million across 5 years, with a median of -$2.2 million in 2023.
- Annual changes were most pronounced in 2024 — Retained Earnings tumbled 450712.5% — and 2025, when it soared 106483.67%.
- Alector's Retained Earnings stood at $798.7 million in 2022, then plunged by 99.98% to $184000.0 in 2023, then sank by 450712.5% to -$829.1 million in 2024, then retreated by 17.24% to -$972.1 million in 2025, then soared by 99.99% to -$104000.0 in 2026.
- Business Quant data shows ALEC's Retained Earnings at -$104000.0 in Q1 2026, -$972.1 million in Q4 2025, and $992.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -1.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 Bn |
| Mar 31, 2026 | -104,000.00 |
| Dec 31, 2025 | -972.06 Mn |
| Sep 30, 2025 | 992.29 Mn |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | -869.60 Mn |
| Dec 31, 2024 | -829.13 Mn |
| Sep 30, 2024 | 931,000.00 |
| Jun 30, 2024 | -784.83 Mn |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Sep 30, 2023 | -668.64 Mn |
| Jun 30, 2023 | -624.17 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | 798.70 Mn |
| Sep 30, 2022 | -6.74 Mn |
| Jun 30, 2022 | 775.84 Mn |
| Mar 31, 2022 | -3.94 Mn |
| Dec 31, 2021 | -943,000.00 |
| Sep 30, 2021 | 726.69 Mn |